Medicinal Product Shortages – update – 23 February 2022

Notice type: Advisory

Date: 23/02/2022

 

Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Anectine 50mg/ml Solution for Injection or Infusion - PA1691/033/001
  • Cisplatin 1mg/ml Concentrate for Solution for Infusion (100ml presentation only) - PA0822/199/001
  • Clexane 4,000 IU (40mg) /0.4 mL Solution for Injection in Pre Filled Syringes - PA0540/097/005
  • Clexane 8,000 IU (80mg) /0.8 mL Solution for Injection in Pre Filled Syringes - PA0540/097/007
  • Divigel 0.1% w/w Gel - PA1327/002/001
  • Fybogel Citrus 3.5g Granules - PA0979/009/001
  • Gaviscon Advance Oral Suspension 500ml - PA0979/011/001
  • Gaviscon Liquid Aniseed Flavour Oral Suspension (300ml presentation only)- PA0979/015/003
  • Gaviscon Oral Suspension- PA0979/015/001
  • Levobupivacaine 7.5mg/ml Solution for Infusion - PA2059/009/005
  • Levofloxacin 5mg/ml Solution for Infusion - PA1122/013/001
  • Piriton 4mg Tablets - PA0678/080/001
  • Rowalief 500mg Film Coated Tablets - PA0074/065/001
  • Tamox 10mg Film Coated Tablets - PA0711/022/001
  • Temodal 5mg Capsules - EU/1/98/096/024
  • Vatan 40mg Tablets - PA0711/183/001
  • Xarelto 1mg/ml Granules for Oral Suspension - EU/1/08/472/050-051

 

The following shortages have been resolved and supply has resumed to the Irish market:

  • Claforan Powder for Solution for Injection 500mg - PA0540/037/002
  • Claforan Powder for Solution for Injection 1g - PA0540/037/003
  • Estradot 100mcg/24 hours, Transdermal Patch - PA0896/010/004
  • Innohep 4,500 IU, Solution for Injection - PA0046/060/007
  • Rifadin 100mg/5ml Oral Suspension - PA0540/066/004
  • Subutex 2mg Sublingual Tablets - PA22617/001/002

Please see the shortages section of the HPRA website for further information.

The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.




« Back